PDSS1
protein-codingdecaprenyl diphosphate synthase subunit 1
Gene summary
The protein encoded by this gene is an enzyme that elongates the prenyl side-chain of coenzyme Q, or ubiquinone, one of the key elements in the respiratory chain. The gene product catalyzes the formation of all trans-polyprenyl pyrophosphates from isopentyl diphosphate in the assembly of polyisoprenoid side chains, the first step in coenzyme Q biosynthesis. The protein may be peripherally associated with the inner mitochondrial membrane, though no transit peptide has been definitively identified to date. Defects in this gene are a cause of coenzyme Q10 deficiency. [provided by RefSeq, Jul 2008]
- TPRT
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~49.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013837
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013837
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013837
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013837
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013837
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *PDSS1* and *PDSS1*-related primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of July 31, 2023. The *PDSS1* gene encodes prenyl diphosphate synthase subunit 1, an enzyme that supplies decaprenyl diphosphate, the precursor for the side chain of the isoprenoid quinone Coenzyme Q10 that functions as a mobile electron carrier in the respiratory chain, as well as other mitochondrial functions including antioxidant properties. A heterodimer is formed by PDSS1 and PDSS2 that functions to isoprenylate benzoquinone in the CoQ10 biosynthesis pathway. The *PDSS1* gene was first reported in relation to *PDSS1*-related primary mitochondrial disease in 2007 (PMID: 17332895). *PDSS1* has been associated with a single disease entity to date, autosomal recessive primary Coenzyme Q10 deficiency 2 [OMIM# 614651]. This is one disease entity according to the ClinGen Lumping and Splitting Framework, and has been renamed as *PDSS1*-related primary mitochondrial disease. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included six unique variants (four missense, two termination) identified in four unrelated cases from four publications (PMIDs: 17332895, 22494076, 34765390, 33285023). Age of onset was early childhood and clinical features in affected individuals include hearing loss, optic atrophy, encephalopathy, livedo reticularis, peripheral neuropathy, nephrotic syndrome, renal failure, pulmonary hypertension, and mild intellectual disability. Brain imaging showed white matter changes and metabolic screening labs showed elevated lactate and decreased Coenzyme Q10. Of note, this expert panel elected to exclude the cases summarized in Jurkute et al., 2022 (PMID: 36266294) given the notable difference in phenotypes reported in this cohort (retinitis pigmentosa and variable hearing loss) and lack of functional evidence providing support for this more mild presentation. The mechanism of disease is loss of function. This gene-disease relationship is also supported by a biochemical function shared with other genes associated with coenzyme Q10 biosynthetic defects and a *Drosophila melanogaster* model (PMIDs: 17332895, 20889762). In summary, there is moderate evidence to support the relationship between *PDSS1* and *PDSS1*-related primary mitochondrial disease. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on July 31, 2023 (SOP Version 10).
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Renal
Intervention: Biochemical
Rationale: There can be a wide range of manifestations, and in some individuals, treatment with Coenzyme Q10 supplementation can be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PDSS1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014317.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 76 | 79 | |||
| missense | 4 | 1 | 148 | 9 | 2 | 164 |
| nonsense | 6 | 3 | 9 | |||
| start loss | 0 | |||||
| frameshift | 2 | 5 | 7 | 14 | ||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 6 | 12 | 164 | 85 | 2 | 269 |
Highest pathogenic variant AF is 0.00002312916
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055132.2 | 12 | MANE Select | |
| Ensembl | ENSP00000365388.5 | 12 | MANE Select | |
| RefSeq | NP_001308907.1 | 10 | Standard | |
| RefSeq | NP_001308908.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Terpenoid backbone biosynthesis - Homo sapiens (human)
- Metabolism
- Ubiquinol biosynthesis
- Metabolism of cofactors
- Metabolism of vitamins and cofactors
Biological Process
- ubiquinone biosynthetic process
- isoprenoid biosynthetic process
- protein heterotetramerization
Molecular Function
- trans-hexaprenyltranstransferase activity
- metal ion binding
- protein heterodimerization activity
- trans-octaprenyltranstransferase activity
Cellular Component
- mitochondrial matrix
- transferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000376215
- Coding exons
- 12
- Length
- 49140
- Individuals with no LoFs
- 125704
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 44
- Defined
- 125748
- p
- 0.000175
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.32 | 161 | 215 | 0.747 | 0.0000124 | 2674 |
| Missense (PolyPhen) | 50 | 82.51 | 0.60598 | 1024 | ||
| Synonymous | 0.766 | 69 | 77.6 | 0.889 | 0.00000476 | 809 |
| Loss of Function | 1.85 | 16 | 26.2 | 0.611 | 0.00000177 | 285 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00018 | 0.00018 | rare |
| European (Non-Finnish) | 0.00021 | 0.00021 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Supplies decaprenyl diphosphate, the precursor for the side chain of the isoprenoid quinones ubiquinone-10. {ECO:0000269|PubMed:16262699}.;
- Disease
- DISEASE: Coenzyme Q10 deficiency, primary, 2 (COQ10D2) [MIM:614651]: An autosomal recessive multisystem disorder characterized by early-onset deafness, optic atrophy, mild mental retardation, peripheral neuropathy, obesity, livedo reticularis, and cardiac valvulopathy. {ECO:0000269|PubMed:17332895}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.290
Intolerance Scores
- LoFtool
- 0.385
- RVIS EVS
- 0.06
- RVIS percentile EVS
- 58.53
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.136
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |